Research Frontiers Incorporated REFR
0.79
0.05
6.76%
as of 25 Sep
- Market cap
- $26.2M
- P/E
- 0.0×
Follow REFR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
27.72 | 45.04 | 39.31 | 43.59 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(94.78) | (41.36) | (94.59) | (372.82) | |
P/B ratio |
16.14 | 17.62 | 47.21 | 35.68 | |
Price to Tangible BV |
16.14 | 17.62 | 47.21 | 35.68 | |
EV/Sales |
26.06 | 43.21 | 38.72 | 42.67 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(10.92) | (20.82) | (32.66) | (64.17) | |
EV/FCF |
(10.92) | (20.81) | (32.64) | (64.05) | |
Quick Ratio |
3.15 | 5.77 | 3.60 | 7.08 | |
Current Ratio |
3.54 | 6.38 | 3.84 | 7.61 | |
Net Debt/EBITDA |
1.74 | 2.63 | 0.91 | 4.40 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.23 | 0.20 | 0.36 | 0.43 | |
Operating CF/Net income |
0.29 | 1.45 | 0.61 | 0.48 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.01) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
149.36% | 106.68% | 187.24% | 39.43% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 276.98% | 0.00% | |
Graham Net Nets |
0.01 | 0.02 | 0.00 | 0.01 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(12.58%) | (7.11%) | (4.22%) | (3.48%) | |
Free Cash Flow Yield |
(8.61%) | (4.61%) | (3.02%) | (1.53%) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.01 | |
Operating CF per Share |
(0.01) | (0.02) | (0.01) | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.01) | (0.02) | (0.01) | 0.00 | |
Cash per Share |
0.03 | 0.04 | 0.02 | 0.03 | |
Shareholders Equity per Share |
0.03 | 0.05 | 0.03 | 0.04 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.03 | 0.05 | 0.03 | 0.04 | |
Free Cash Flow |
(0.19) | (0.76) | (0.47) | (0.14) | |
Working Capital |
1.04 | 1.70 | 0.85 | 1.40 | |
Capital Expenditures |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Current Asset Value |
0.10 | 0.72 | (0.17) | 0.35 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(765.01%) | (385.47%) | (1,061.86%) | (83.06%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.37 | 0.76 | 0.53 | 0.71 | |
Average Payables |
0.08 | 0.06 | 0.11 | 0.03 | |
Average Assets |
2.82 | 3.42 | 3.15 | 2.88 | |
Average Common Equity |
1.46 | 2.11 | 1.77 | 2.16 |
Columns are period end dates